HIGHBRIDGE CAPITAL MANAGEMENT LLC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-25 10:44 am Sale |
2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0.000% |
-145,847 (Position Closed) |
Filing |
| 2022-02-03 08:27 am Purchase |
2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 145,847 6.340% |
145,847 (New Position) |
Filing |